HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

At Nuvothera, Rx Derma Veterans Develop OTCs For Serious Skin Conditions

Executive Summary

Firm launched Prosoria in 2018 as a four-product topical line for inflammatory autoimmune disease psoriasis containing salicylic acid 3% combined with turmeric and other botanicals. CEO Arthur Clapp says firm will launch turmeric supplements and plans adding products for acne, eczema, warts, nail fungus and rosacea.

You may also be interested in...



Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval

Galderma Labs' adapalene gel is pending launch as first OTC acne ingredient approved through an NDA and first new acne ingredient available OTC in 20 years, but company must play in a digitally-oriented marketplace.

US State Laws To Address Packaging Waste Are Cosmetics Industry’s Newest Patchwork Problem

Beauty and personal-care companies building a compliance strategy across states should consider starting with California’s SB-54, as it is the “strictest law in place,” experts agreed at the Independent Beauty Association’s recent Supply Chain & Sustainability Conference. They encouraged companies to assess packaging across SKUs and participate in state-level regulatory development processes.

Beauty Industry Grapples With Preservation Challenges Ahead Of Washington State CH₂O-Releaser Bans

Experts at the Independent Beauty Association’s Supply Chain & Sustainability Conference discussed the personal-care industry’s preservatives crisis and how industry is responding to Washington State’s coming ban on cosmetics products containing formaldehyde releasers.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148540

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel